CVE-2026-79314 vaxilu CVE debrief

Who should care

Defenders who are responsible for systems using x-ui 0.3.2 should care about this vulnerability. They should assess exposure and prioritize verifying the impact of this vulnerability on their systems.

Why it matters

CVE-2026-79314 is a high-severity vulnerability in x-ui 0.3.2 that allows authenticated users to escalate privileges horizontally. Defenders should prioritize verifying exposure and assessing the impact of this vulnerability on their systems.

• Defenders need to verify exposure and assess the impact of this vulnerability on their systems.
• Defenders should monitor for suspicious activity and apply patches or mitigations as soon as they are available.
• Defenders need to prioritize patching or mitigating this vulnerability to prevent unauthorized cross-user modification of data.

Technical summary

A horizontal privilege escalation vulnerability exists in x-ui 0.3.2. An authenticated user can modify the inbound proxy configurations of other users, including remark, port, protocol, settings, enabled state, expiry time and traffic quota, by submitting a request referencing the target resource identifier. The update path fails to verify that the target resource belongs to the requesting session user, allowing unauthorized cross-user modification of data.

Defensive priority

Defenders should prioritize verifying exposure and assessing the impact of this vulnerability on their systems, especially if they are using x-ui 0.3.2. They should also monitor for any suspicious activity and apply patches or mitigations as soon as they are available.

Recommended defensive actions

• Verify if the system is using x-ui 0.3.2 and assess exposure
• Monitor for suspicious activity
• Apply patches or mitigations as soon as they are available
• Review compensating controls for exposed systems while remediation is scheduled and verified
• Check relevant monitoring, detection, and logs for exposed assets that need extra review
• Track exceptions, retest remediated assets, and close the item only after evidence is documented
• Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up

Evidence notes

The evidence for this vulnerability comes from the CVE Program record and the NVD vulnerability detail page. The CVE description provides details on the vulnerability, including its CVSS score and severity.

Sources and references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.